6505--Alendronate Tablets Effective 05/21/2026 - 05/20/2027

Award Notice Posted

Solicitation number
36E79725R0069
Agency
Awarded
to Marlex Pharmaceuticals Inc.
Set-aside
No set-aside

Opportunity facts

Contract number
36E79726D0016 Federal IDV award

Notice details come from SAM.gov. Updated .

About this opportunity

The Department of Veterans Affairs National Acquisition Center awarded contract 36E79726D0016 to MARLEX PHARMACEUTICALS INC on January 7, 2025, for the supply of Alendronate Tablets. The contract is valued at $4,350,222.40 and covers a one-year performance period from May 21, 2026, through May 20, 2027. This award notice, posted on January 8, 2026, indicates that MARLEX PHARMACEUTICALS INC, located in New Castle, Delaware, has been selected as the contractor for this pharmaceutical supply requirement under solicitation number 36E79725R0069, with no set-aside provisions applied to the competition.

Notice text

Awarded contract 36E79726D0016 to MARLEX PHARMACEUTICALS INC for 4350222.40 on 2025-01-07.

Files

File Type Posted
36E79726D0016_1.docx DOCX document

Notice history

Notice Type Posted
This notice Award Award Notice
6505--Alendronate Tablets Latest solicitation Solicitation
6505--Alendronate Tablets Original Pre-Solicitation

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity